(Total Views: 484)
Posted On: 05/05/2025 11:03:21 AM
Post# of 154593

Re: KenChowder #152279
Ken: Thanks for the reply. My first exposure to LL was during the cytokine storm analysis where LL optimally brought down the ultra-high CCR5 count.
As per Ohm, in TNBC in normal breast tissue initially and normally there is a low CCR5 count which then rises after the onset of breast cancer. In this case, is LL's optimal result a modulated increase of the CCR5 count or decrease of the CCR5 count in the TNBC patient?
As per Ohm, in TNBC in normal breast tissue initially and normally there is a low CCR5 count which then rises after the onset of breast cancer. In this case, is LL's optimal result a modulated increase of the CCR5 count or decrease of the CCR5 count in the TNBC patient?

